PCVX as of Nov 4 · 14:39 ET
PCVXNasdaqBiological Products, (No Diagnostic Substances)
Vaxcyte, Inc. · Brief
Next report
5 days
Nov 9 · after closeest.Q3 FY26
Expected move
Inputs1 of 8≥ implied
- avg implied
- ±10.9%
- avg realized
- ±5.3%
Nov 5 '24±5.1%▼−3.24%×0.64
Feb 25 '25±16.1%▼−0.88%×0.05
May 7 '25±11.9%▲+8.45%×0.71
Aug 6 '25±10.9%▼−9.06%×0.83
Nov 4 '25±16.7%▼−2.49%×0.15
Q1 FY26±10.5%▲+2.75%×0.26
May 6 '26±7.2%▼−9.84%×1.36
Q2 FY26±8.6%▲+5.31%×0.62
quarterimplied−20%0+20%realized×
Q2 FY26±8.6%▲+5.31%×0.62
May '26±7.2%▼−9.84%×1.36
Q1 FY26±10.5%▲+2.75%×0.26
Nov '25±16.7%▼−2.49%×0.15
Aug '25±10.9%▼−9.06%×0.83
May '25±11.9%▲+8.45%×0.71
2 older reports
Feb '25±16.1%▼−0.88%×0.05
Nov '24±5.1%▼−3.24%×0.64
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close
Bull & bear
Nov 9 report · est.Bull2
Bear1
AI captions · Sep 16 '26once per report · top 2 per case
Linked exposure
PCVX report session× = co-movement · max 499dSource: SEC filings · market data
Your note
privateThesis 0 · Decisions 0 · Observations 0
No thesis.